Metsep P 1mg/500mg/15mg Tablet SR
Marketer
Sepik Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metsep P 1mg/500mg/15mg Tablet SR
Glimepiride/Metformin/Pioglitazone extended-release tablets (1mg/500mg/15mg) are a triple-combination therapy managing blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing elevated blood sugar. Dosage and duration should strictly follow your physician's instructions. Administer with food to prevent gastric distress. For missed doses, take immediately unless nearing the next scheduled dose; in that case, omit the missed dose and resume the normal schedule. Never double the dose. Overdosage can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol, or skipped meals elevates the hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any renal, hepatic, or cardiac conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be assessed before commencing therapy. Limit alcohol consumption as it may exacerbate side effects.
Uses of Metsep P 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metsep P 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metsep P 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Metsep P 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metsep P 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metsep P 1mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.
How Metsep P 1mg/500mg/15mg Tablet SR works:
Metsep P 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions—to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Metsep P 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Metsep P 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Metsep P 1mg/500mg/15mg tablets are likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Metsep P 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Metsep P 1mg/500mg/15mg SR tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Metsep P 1mg/500mg/15mg SR tablets. Dosage modification of Metsep P 1mg/500mg/15mg SR tablets may be necessary. Physician consultation is advised. Metsep P 1mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Metsep P 1mg/500mg/15mg Tablet SR :
Should you forget to take a Metsep P 1mg/500mg/15mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metsep P 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently